APPOINTS NEW BOARD MEMBER
BETHESDA, MARYLAND, December 12, 2000 – Chindex International, Inc. (NASDAQ:CHDX) (U.S.-China Industrial Exchange, Inc.), the leading independent American company providing Western healthcare products distribution and medical services in the People’s Republic of China, today announced the appointment of Carol R. Kaufman to the Company’s Board of Directors.
Ms. Kaufman is currently the Vice President of Legal Affairs, Secretary and Chief Administrative Officer of The Cooper Companies, Inc. (NYSE: COO), a position that she has held since October 1995. Prior to this, she served as Vice President, Secretary, and Chief Administrative Officer of Cooper Development Company, a healthcare and consumer products company that was a former affiliate of The Cooper Companies, Inc., and held numerous financial positions with Cooper Laboratories, Inc., its parent company.
Ms. Kaufman is a member of the Executive Committee of The Olympic Club Foundation, a non-profit organization dedicated to raising and distributing funds to support athletic programs for under-privileged youth in the San Francisco Bay Area. She is also a member of various other organizations benefiting Bay Area youth and has served as a Trustee of the Monterey Institute of International Studies.
"We are very pleased that Carol has joined our Board," said Roberta Lipson, Chindex President, Chairperson and CEO. "Carol brings to Chindex an added dimension of professionalism, outstanding qualifications, particularly in the financial area, as well as bountiful executive experience in board matters."
Chindex is a leading American company in healthcare in the Greater Chinese marketplace including Hong Kong. It provides representative and distribution services to a number of major multinational companies including Acuson (diagnostic ultrasound scanners), Johnson & Johnson (clinical chemistry analyzers), Guidant (interventional cardiology products including stents, balloon catheters, and guide wires), Becton Dickinson (including hypodermic needles and syringes, infusion therapy systems, critical care systems, preanalytical solutions, and consumer healthcare products) and Tyco/Kendall Healthcare Products (including brands such as Davis & Geck, Sherwood, Kendall, Sheridan, and Curity). It also provides healthcare services through the operations of its private hospital corporation in China. With nearly twenty years of experience, approximately 330 employees, and operations in the United States, China and Hong Kong, the Chindex strategy is to expand its cross-cultural reach by providing leading edge technologies, quality products and services to Greater China's professional communities. Further company information may be found at the Chindex website, www.chindex.com.
Copyright © 1997 U.S.-China Industrial Exchange, Inc. All Rights Reserved.